Short-term sleep improvement; REM suppression and tolerance with THC
Sleep disorders are among the most common reasons people use cannabis. THC reduces sleep onset latency and increases slow-wave sleep short-term, but suppresses REM sleep and causes tolerance with chronic use. CBD may improve sleep in patients with anxiety-related insomnia via anxiolytic mechanisms. The long-term sleep effects of cannabis are complex and not fully characterized.
Medical Disclaimer: Chronic cannabis use can worsen sleep quality long-term. CBT-I (cognitive behavioral therapy for insomnia) is the first-line treatment for insomnia. Consult a sleep specialist before using cannabis for sleep disorders.
Insomnia affects approximately 30% of adults, and chronic insomnia disorder affects 10%. Conventional treatments (CBT-I, benzodiazepines, Z-drugs) have significant limitations. Cannabis is one of the most commonly cited reasons for medical cannabis use, with sleep problems reported by 40–50% of medical cannabis patients. THC's acute sleep effects are well-characterized: it reduces sleep onset latency, increases slow-wave (deep) sleep, and suppresses REM sleep. REM suppression reduces dreaming and nightmares — beneficial for PTSD but potentially problematic for memory consolidation and emotional processing. With chronic THC use, tolerance to sleep effects develops within weeks, and REM rebound (increased dreaming and vivid nightmares) occurs upon cessation. CBN is widely marketed as a sleep aid, but clinical evidence for CBN-specific sleep effects is limited — its sedative reputation may reflect the terpene profile of aged cannabis rather than CBN itself. CBD may improve sleep in patients with anxiety-related insomnia by reducing anxiety, but evidence for direct sleep effects is mixed. A 2019 study by Shannon et al. showed CBD improved sleep scores in 66% of patients in the first month, though effects fluctuated over time.
Evidence summary for cannabinoid-based interventions in Sleep Disorders.
Mechanism: CB1 agonism reduces sleep onset latency, increases slow-wave sleep, suppresses REM sleep; sedating terpenes (myrcene) may contribute
Clinical Status: Multiple observational studies; limited RCT evidence for insomnia specifically
Effective short-term for sleep onset. Tolerance develops within 2–4 weeks. REM suppression may impair emotional processing. Rebound insomnia and vivid dreams upon cessation. Not recommended for long-term insomnia management.
Mechanism: Anxiolytic effects (5-HT1A agonism) may improve sleep in anxiety-related insomnia; direct sleep effects are less clear
Clinical Status: Limited RCT evidence for sleep specifically; ongoing trials
Non-psychoactive. May be more appropriate for long-term use than THC. Best evidence is for anxiety-related insomnia. High doses (160mg) may increase sleep duration; low doses may be alerting.
Mechanism: Weak CB1 agonism; may have mild sedative effects; often combined with THC in sleep products
Clinical Status: No completed RCTs for sleep; widely marketed but evidence is anecdotal
CBN's sleep reputation is largely based on anecdote and marketing. The sedative effects of aged cannabis may reflect terpene profiles rather than CBN. A 2023 study found CBN alone did not improve sleep vs. placebo.
Peer-reviewed research on cannabinoids and Sleep Disorders.
Shannon S, Lewis N, Lee H, et al. · The Permanente Journal
Retrospective case series of 72 patients: CBD (25–175mg/day) improved sleep scores in 66.7% of patients in the first month. Anxiety improved in 79.2%. Effects fluctuated over time.
View on DOI.orgBabson KA, Sottile J, Morabito D · Current Psychiatry Reports
Comprehensive review finding THC reduces sleep onset latency and increases slow-wave sleep short-term but suppresses REM sleep. CBD may have therapeutic potential for REM sleep behavior disorder and excessive daytime sleepiness.
View on DOI.orgWare MA, Fitzcharles MA, Joseph L, et al. · Journal of Clinical Psychopharmacology
Nabilone (0.5–1mg) significantly improved sleep quality vs. amitriptyline in fibromyalgia patients, with superior restfulness and reduced pain.
View on DOI.orgTHC reduces sleep onset latency and increases deep sleep short-term. However, it suppresses REM sleep, and tolerance develops within weeks. Long-term cannabis use is associated with worse sleep quality overall. CBD may help with anxiety-related insomnia but has less evidence for direct sleep effects.
Yes — THC significantly suppresses REM sleep. This reduces dreaming and nightmares (beneficial for PTSD) but may impair memory consolidation and emotional processing. When cannabis is stopped after regular use, REM rebound occurs — vivid dreams and nightmares for 1–2 weeks.
The evidence for CBN as a sleep aid is very limited. No completed RCTs support CBN-specific sleep effects. A 2023 study found CBN alone did not improve sleep vs. placebo. CBN's sedative reputation may reflect the terpene profile of aged cannabis. CBT-I (cognitive behavioral therapy for insomnia) has much stronger evidence.
Yes — paradoxically, chronic cannabis use is associated with insomnia. Tolerance to THC's sleep effects develops within weeks. Cannabis use disorder is associated with significant sleep disturbance. Withdrawal from regular cannabis use causes rebound insomnia that can last 1–3 weeks.
